3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Osteonecrosis of the femoral head (ONFH) commonly occurs after glucocorticoid (GC) therapy. The gut microbiota (GM) participates in regulating host health, and its composition can be altered by GC. Here, this study demonstrates that cohousing with healthy mice or colonization with GM from normal mice attenuates GC-induced ONFH. 16 S rRNA gene sequencing shows that cohousing with healthy mice rescues the GC-induced reduction of gut Lactobacillus animalis. Oral supplementation of L. animalis mitigates GC-induced ONFH by increasing angiogenesis, augmenting osteogenesis, and reducing cell apoptosis. Extracellular vesicles from L. animalis ( L. animalis-EVs) contain abundant functional proteins and can enter the femoral head to exert proangiogenic, pro-osteogenic, and antiapoptotic effects, while its abundance is reduced after exposure to GC. Our study suggests that the GM is involved in protecting the femoral head by transferring bacterial EVs, and that loss of L. animalis and its EVs is associated with the development of GC-induced ONFH.

          Abstract

          Abstract

          Gut bacteria secrete extracellular vesicles that prevent glucocorticoid-induced osteonecrosis.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

          T cell infiltration of solid tumors is associated with favorable patient outcomes, yet the mechanisms underlying variable immune responses between individuals are not well understood. One possible modulator could be the intestinal microbiota. We compared melanoma growth in mice harboring distinct commensal microbiota and observed differences in spontaneous antitumor immunity, which were eliminated upon cohousing or after fecal transfer. Sequencing of the 16S ribosomal RNA identified Bifidobacterium as associated with the antitumor effects. Oral administration of Bifidobacterium alone improved tumor control to the same degree as programmed cell death protein 1 ligand 1 (PD-L1)-specific antibody therapy (checkpoint blockade), and combination treatment nearly abolished tumor outgrowth. Augmented dendritic cell function leading to enhanced CD8(+) T cell priming and accumulation in the tumor microenvironment mediated the effect. Our data suggest that manipulating the microbiota may modulate cancer immunotherapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

            A key role of the gut microbiota in the establishment and maintenance of health, as well as in the pathogenesis of disease, has been identified over the past two decades. One of the primary modes by which the gut microbiota interacts with the host is by means of metabolites, which are small molecules that are produced as intermediate or end products of microbial metabolism. These metabolites can derive from bacterial metabolism of dietary substrates, modification of host molecules, such as bile acids, or directly from bacteria. Signals from microbial metabolites influence immune maturation, immune homeostasis, host energy metabolism and maintenance of mucosal integrity. Alterations in the composition and function of the microbiota have been described in many studies on IBD. Alterations have also been described in the metabolite profiles of patients with IBD. Furthermore, specific classes of metabolites, notably bile acids, short-chain fatty acids and tryptophan metabolites, have been implicated in the pathogenesis of IBD. This Review aims to define the key classes of microbial-derived metabolites that are altered in IBD, describe the pathophysiological basis of these associations and identify future targets for precision therapeutic modulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi.

              Extracellular vesicles (EVs) are produced by all domains of life. In Gram-negative bacteria, EVs are produced by the pinching off of the outer membrane; however, how EVs escape the thick cell walls of Gram-positive bacteria, mycobacteria and fungi is still unknown. Nonetheless, EVs have been described in a variety of cell-walled organisms, including Staphylococcus aureus, Mycobacterium tuberculosis and Cryptococcus neoformans. These EVs contain varied cargo, including nucleic acids, toxins, lipoproteins and enzymes, and have important roles in microbial physiology and pathogenesis. In this Review, we describe the current status of vesiculogenesis research in thick-walled microorganisms and discuss the cargo and functions associated with EVs in these species.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: Formal analysisRole: Funding acquisitionRole: InvestigationRole: Validation
                Role: Investigation
                Role: Investigation
                Role: InvestigationRole: Validation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Investigation
                Role: Resources
                Role: Resources
                Role: Investigation
                Role: ResourcesRole: Software
                Role: ConceptualizationRole: Data curationRole: Funding acquisitionRole: Project administrationRole: ResourcesRole: SupervisionRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                April 2022
                13 April 2022
                : 8
                : 15
                : eabg8335
                Affiliations
                [1 ]Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
                [2 ]Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
                [3 ]Xiangya School of Nursing, Central South University, Changsha, Hunan 410013, China.
                [4 ]Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510220, China.
                [5 ]Department of Occupational and Environmental Health, Xiangya School of Public Health, Central South University, Changsha, Hunan 410078, China.
                [6 ]Department of Sports Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
                [7 ]Hunan Key Laboratory of Organ Injury, Aging and Regenerative Medicine, Changsha, Hunan 410008, China.
                [8 ]Hunan Key Laboratory of Bone Joint Degeneration and Injury, Changsha, Hunan 410008, China.
                [9 ]National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
                Author notes
                [* ]Corresponding author. Email: huixie@ 123456csu.edu.cn
                Author information
                https://orcid.org/0000-0001-7808-533X
                https://orcid.org/0000-0002-8526-2637
                Article
                abg8335
                10.1126/sciadv.abg8335
                9007505
                35417243
                77a7d9bc-dc9b-4f3b-91d2-8516198cc2fa
                Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 30 January 2021
                : 24 February 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: Grant Nos. 81871822, 82072504, 81670807, 81522012, 81702237, 81974127
                Funded by: Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences;
                Award ID: Grant No. 2019-RC-HL-024
                Funded by: Innovation Driven Project of Central South University;
                Award ID: Grant No. 2019CX014
                Funded by: Hunan Province Natural Science Foundation of China;
                Award ID: Grant No. 2020JJ5883
                Funded by: Free Exploration Program of Central South University;
                Award ID: Grant No. 502221901
                Funded by: Science and Technology Innovation Program of Hunan Province;
                Award ID: Grant No. 2020RC4008
                Funded by: Special Funding for the Construction of Innovative Provinces in Hunan;
                Award ID: Grant Nos. 2019SK2301, 2020SK3002
                Funded by: Science and Technology Plan Project of Hunan Province;
                Award ID: Grant Nos. 2017XK2039, 2018RS3029
                Categories
                Research Article
                Biomedicine and Life Sciences
                SciAdv r-articles
                Diseases and Disorders
                Microbiology
                Diseases and Disorders
                Custom metadata
                Adrienne Del Mundo

                Comments

                Comment on this article